Intimal deposition of functional von Willebrand factor in atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2524-2534

  De Meyer, Guido R Y ^c   Hoylaerts, Marc F ^b   Kockx, Mark M ^a   Yamamoto, Hiroshi ^b   Herman, Arnold G ^d   Bult, Hidde ^d  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d NONE

Author keywords

Atherosclerosis; Hyperlipidemia; Intima; Reverse transcription polymerase chain reaction; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RABBIT; THROMBOCYTE ADHESION; TISSUE DISTRIBUTION;

EID: 0032833720     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2524     Document Type: Article

References (45)

1. De Meyer GRY, Van Put DJM, Kockx MM, Van Schil P, Bosmans R, Bult H, Buyssens N, Vanmaele R, Herman AG. Possible mechanisms of collar-induced intimai thickening. Arterioscler Thromb Vasc Biol. 1997; 17:1924-1930.
2. Kockx MM, De Meyer GRY, Andries LJ, Bult H, Jacob WA, Herman AG. The endothelium during cuff induced neo-intima formation in the rabbit carotid artery. Arterioscler Thromb. 1993;13:1874-1884.
3. Booth RFG, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis. 1989;76: 257-268.
4. Wagner D. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217-246.
5. Loesberg C, Gonsalves MD, Zandbergen J, Willems C, van Aken WG, Stel HV, Van Mourik JA, De Groot PG. The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta. 1983;763:160-168.
6. Ruggeri ZM, Ware J. von Willebrand factor. FASEB J. 1993;7:308-316.
7. Nichols TC, Bellinger DA, Reddick RL, Koch GG, Sigman JL, Erickson G, du Laney T, Johnson T, Read MS, Griggs TR. von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress. Arterioscler Thromb Vasc Biol. 1998;18:323-330.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
9. Harris DE, Warshaw DM, Periasamy M. Nucleotide sequences of the rabbit α-smooth-muscle and β-non-muscle actin mRNAs. Gene. 1992; 112:265-266.
10. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HF, Connolly TM, de Groot PG, Sixma J. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest. 1994;93:615-632.
11. Hoylaerts MF, Yamamoto H, Vermylen J. Platelet adhesion to non-damaged aorta endothelium of cholesterol-fed rabbits is mediated by von Willebrand factor (vWF). Thromb Haemost. 1997;9(Suppl):344. Abstract.
12. Yamamoto H, Vreys I, Stassen JM, Yoshimoto R, Vermylen J, Hoylaerts MF. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster. Thromb Haemost. 1998;79:202-210.
13. Ghadially FN. Rod-shaped microtubulated bodies. In: Ultrastructural pathology of the cell and matrix. A text and atlas of physiological and pathological alterations in the fine structure of cellular and extracellular components. Vol 2. 3rd ed. London: Butterworths; 1988:827-837.
14. Kockx MM, De Meyer GRY, Buyssens N, Knaapen MWM, Bult H, Herman AG. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res. 1998;83:378-387.
15. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large biologically potent von Willebrand factor multimers. Cell. 1986;46:185-190.
16. Bürrig KF. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb. 1991;11:1678-1689.
17. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 1995;25(Suppl 2):S9-S12.
18. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.
19. Ferran C, Millan MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH, Winkler H. Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun. 1995;214:212-223.
20. Lin JH, Zhu Y, Liao HL, Kobari Y, Groszek L, Stemerman MB. Induction of vascular cell adhesion molecule-1 by low-density lipoprotein. Atherosclerosis. 1996;127:185-194.
21. Sugiyama S, Kugiyama K, Ogata N, Doi H, Ota Y, Ohgushi M, Matsumura T, Oka H, Yasue H. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol. 1998;18:568-576.
22. Nordoy A, Killie JE, Badimon L, Fass DN, Mao SJ, Maciejko JJ. The effect of lipoproteins on the synthesis of prostacyclin, von Willebrand factor and apolipoproteins A-I and A-II in cultured human endothelial cells. Atherosclerosis. 1984;50:307-323.
23. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost. 1996;76:663-669.
24. Blann AD, Miller JP, McCollum CN. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia. Atherosclerosis. 1997;132:151-156.
25. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255-265.
26. Montalescot G, Philippe F, Ankri A, Vicaut E, Bearez E, Poulard JE, Carrie D, Flammang D, Dutoit A, Carayon A, Jardel C, Chevrot M, Bastard JP, Bigonzi F, Thomas D, for the French Investigators of the ESSENCE trial. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease. Benificial effects of enoxaparin. Circulation. 1998;98:294-299.
27. Mannucci PM, von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18:1359-1362.
28. Galbusera M, Zoja C, Donadelli R, Paris S, Morigi M, Benigni A, Figliuzzi M, Remuzzi G, Remuzzi A. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. Blood. 1997;90:1558-1564.
29. Ceponis A, Konttinen YT, MacKevicius Z, Solovieva SA, Hukkanen M, Tamulaitiene M, Matulis A, Santavirta S. Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. J Rheumatol. 1996;23:1880-1886.
30. Schorer AE, Moldow CF, Rick ME. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Br J Haematol. 1987;67:193-197.
31. Giddings JC, Shall L. Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1. Thromb Res. 1987;47:259-267.
32. Hakkert BC, Rentenaar JM, van Mourik JA. Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types. Br J Haematol. 1992;80:495-503.
33. de Groot PG, Verweij CL, Nawroth PP, de Boer HC, Stern DM, Sixma JJ. Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets. Arteriosclerosis. 1987;7:605-611.
34. Breit SN, Green I. Modulation of endothelial cell synthesis of von Willebrand factor by mononuclear cell products. Haemostasis. 1988;18: 137-145.
35. Bosmans JM, Kockx MM, Vrints CJ, Bult H, De Meyer GRY, Herman AG. Fibrin and von Willebrand factor accumulation are associated with intimai thickening after balloon angioplasty. Arterioscler Thromb Vasc Biol. 1997;17:634-645.
36. Giddings JC, Banning AP, Ralis H, Lewis MJ. Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty. Arterioscler Thromb Vasc Biol. 1997;17:1872-1878.
37. Reidy MA, Chopek M, Chao S, Mc Donald T, Schwartz SM. Injury induces increase of von Willebrand factor in rat endothelial cells. Am J Pathol. 1989;194:857-864.
38. Sussman II, Rand JH. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. J Lab Clin Med. 1982; 100:526-532.
39. Slomp J. Changes in phenotype of vascular smooth muscle and endothelial cells during the development of intimai thickening [PhD thesis]. Rijksuniversiteit Leiden. 1995 (ISBN 90-9008485-1).
40. Golino P, Ambrosio G, Ragni M, Cirillo P, Esposito N, Willerson JT, Rothlein R, Petrucci L, Condorelli M, Chiariello M, Buja LM. Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury. Thromb Haemostas. 1997;77:783-788.
41. Fuster VEJ, Bowie W, Lewis JC, Fass DN, Owen CA, Brown AL. Resistance to arteriosclerosis in pigs with von Willebrand's disease. J Clin Invest. 1978;61:722-730.
42. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost. 1993;70:111-118.
43. Nichols TC, Bellinger DA, Tate DA, Reddick RL, Read MS, Koch GG, Brinkhous KM, Griggs TR. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis. 1990;10:449-461.
44. Nichols TC, Bellinger DA, Reddick RL, Read MS, Koch GG, Brinkhous KM, Griggs TR. Role of von Willebrand factor in arterial thrombosis. Studies on normal and von Willebrand disease pigs. Circulation. 1991; 83(Suppl 6):IV-56-IV-64.
45. Federici AB, Mannucci PM, Fogato E, Ghidoni P, Matturri L. Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi. Thromb Haemost. 1993;70:758-761.